Hippo ERcast October 2025

In Flight Emergencies

In-flight medical emergencies are uncommon but high-stakes, and emergency clinicians are often the best-equipped responders when a commercial flight asks for medical help. U.S. Good Samaritan protection is broad under the Aviation Medical Assistance Act, and practical care depends on onboard kit limits, ground medical control, and tight cabin-space improvisation. Responding to In-Flight Emergencies Legal protection framework: The 1998 Aviation Medical Assistance Act broadly protects clinicians who render aid on aircraft, with liability mainly turning on gross negligence or willful misconduct. Ground medical control backup: Airline crews can connect you to ground-based medical control, so the bedside assessment is yours but treatment and diversion decisions are shared rather than solo. Pilot authority limits: Diversion recommendations matter, but the final decision belongs to the pilot, a practical boundary that changes how you frame urgency and risk in the cabin. Onboard equipment reality: Commercial aircraft medical kits are closer to enhanced first-aid kits than ED carts, usually centered on an AED, oxygen, epinephrine, and a small set of IV medications. We walk through the usual onboard resources in the episode. Cabin resuscitation logistics: The back galley's T-shaped space near the exits offers the best working area, and lining the chest up with the lavatories can make CPR physically possible. Passenger resource crowdsourcing: Other travelers can unexpectedly fill gaps with personal meds or devices such as a glucometer or nitroglycerin, a useful move when the aircraft kit runs thin.

Lit Matters 1: Lifetime cancer risk from CT

CT imaging is a major source of medical ionizing radiation, and current U.S. use may account for about 5% of future annual cancer diagnoses if present patterns persist. Risk is highest per exam in younger patients, but adults drive most projected cancers because CT volume is so high. Lifetime cancer risk from CT Population radiation burden: Modeled 2023 U.S. CT use totaled 93 million exams in 61.5 million patients, with roughly 103,000 projected radiation-induced cancers if current imaging patterns and doses continue. Adult volume dominates harm: Children carry higher per-exam risk, but adults account for 91% of projected cancers because nearly 90 million scans were performed in adults. Highest-risk scan groups: Abdomen-pelvis CT generated the largest share of projected adult cancers at 40%, while head CT drove 53% of projected cancers in children. Age-related risk gradient: Radiation-related cancer risk falls with increasing age at exposure; in girls younger than 1 year, the modeled risk approached 20 cancers per 1000 CT exams. Most common projected cancers: Lung cancer led the adult projections, followed by colon cancer and leukemia; thyroid cancer was the leading projected malignancy in children, a pattern we put in clinical context in the episode. Practice implication: CT remains diagnostically invaluable, but this paper argues for stricter indication discipline and dose stewardship because delayed radiation harm is real and rarely attributable at the bedside.

Multiple Sclerosis: A patient's experience in the ED

Multiple sclerosis patients often come to the ED for infection, pain, falls, bladder dysfunction, or medication effects rather than a true inflammatory relapse. A real relapse means new or worsening neurologic deficits lasting more than 24 hours without fever or infection, and high-dose corticosteroids remain first-line therapy. MS Relapse Versus Pseudoexacerbation True relapse definition: A true MS relapse is a new neurologic deficit or worsening of prior symptoms lasting more than 24 hours in the absence of fever or infection, a distinction that drives everything else in the workup. Infection-first diagnostic frame: UTIs and other infections commonly trigger pseudoexacerbations, so CBC, chemistries, urinalysis, and targeted cultures come before labeling worsening symptoms as new demyelinating disease. Non-inflammatory ED presentations: Most ED visits in MS are not acute relapses but pain, fatigue, falls, urinary complaints, medication effects, or mental health symptoms. That early split is worth hearing in the episode. Focused neurologic comparison: The bedside exam hinges on documenting what is truly new versus baseline deficits, because patients often carry chronic weakness, sensory loss, gait instability, or visual symptoms. MRI as confirmatory test: MRI brain or spine with gadolinium is the gold standard for showing new lesions, but it is often unnecessary from the ED unless neurology needs it for diagnostic uncertainty or disposition. ED Management And Disposition Steroid first-line therapy: High-dose IV methylprednisolone is the cornerstone of acute relapse treatment, with oral high-dose steroids sometimes used when neurology agrees and outpatient logistics are reliable. Symptom-directed treatment priorities: Spasticity, neuropathic pain, fatigue, bladder dysfunction, and dysphagia often need more ED attention than immunotherapy, with sedation and aspiration risk shaping early choices. Polypharmacy and immunosuppression: Many MS patients take disease-modifying and symptomatic drugs simultaneously, raising the stakes for drug interactions, steroid adverse effects, and opportunistic infection. Neurology consultation threshold: Neurology is almost always involved for true relapses, management changes, refractory symptoms, or diagnostic uncertainty. We get into the practical consult threshold in the chapter. Admission red flag features: New inability to ambulate, dysphagia, vision loss, need for PLEX or IVIG, or major diagnostic uncertainty should push disposition toward admission rather than reflexive discharge.

Amyotrophic lateral sclerosis - ALS

Amyotrophic lateral sclerosis is a progressive motor neuron disease marked by combined upper and lower motor neuron findings, bulbar dysfunction, and eventual respiratory failure. In the ED, the high-yield questions are recognizing the pattern, excluding reversible mimics, and handling respiratory decline and goals-of-care early. ALS recognition and emergency evaluation Mixed motor neuron signs: Concurrent upper and lower motor neuron findings are the bedside red flag for ALS, with hyperreflexia and spasticity alongside atrophy, fasciculations, or hyporeflexia. Limb versus bulbar onset: Limb-onset disease accounts for about 70% of presentations, while bulbar onset more often starts with dysarthria and dysphagia before limb weakness becomes prominent. ALS-plus features: Sensory loss, ocular motility disturbance, autonomic dysfunction, or extrapyramidal findings should push you to think beyond classic ALS and broaden the differential. Cognitive and behavioral overlap: Frontotemporal involvement is common, with about 15% meeting criteria for frontotemporal dementia and many more showing executive or behavioral change, a nuance we get into in the episode. Initial ED workup: Start like any suspected neurologic disorder with basic labs and head CT to exclude other pathology, then prioritize urgent neurology follow-up if the patient is stable for discharge. Follow-up urgency: A possible new ALS diagnosis should not sit on a routine referral queue; neurology review within 1-2 weeks is the practical target, and calling from the ED can accelerate access. Respiratory failure, prognosis, and goals of care Linear disease progression: ALS typically progresses without remissions, spreading from focal weakness to broader limb and bulbar involvement in a fairly predictable pattern rather than relapsing flares. Prognosis worth naming early: ALS is terminal: roughly 50% of patients die within 3 years of diagnosis, and only about 10% live beyond 10 years. Respiratory weakness pattern: Chronic respiratory failure usually reflects diaphragmatic and intercostal muscle weakness rather than primary lung disease, which changes how you frame deterioration at the bedside. NIV as key support: Noninvasive ventilation can reduce symptoms and prolong life, and acute pulmonary instability in ALS generally warrants admission when NIV initiation is on the table. We walk through the practical framing in the chapter. Search for reversible triggers: Acute respiratory decompensation in ALS still demands a hunt for pneumonia, pneumothorax, and other superimposed causes rather than assuming pure disease progression. Early end-of-life planning: Goals-of-care discussions belong early after diagnosis, especially around tracheostomy, gastrostomy, and communication of future preferences so unwanted emergency interventions are less likely. Symptom management and ventilator care Modest disease-modifying therapy: Riluzole modestly extends survival by about 3-6 months, so day-to-day ED care remains centered on symptom control and complications rather than dramatic reversal. Pain treatment priorities: Pain is common from cramps, immobility, and pressure injury, with acetaminophen or NSAIDs as first-line options and gabapentin or muscle relaxants as common adjuncts. Opioid ventilation caution: Opioids deserve extra caution in ALS because respiratory reserve is already limited, making sedating analgesia a bigger hazard than in many other chronic neurologic illnesses. Nutrition and secretion burden: Dysphagia, constipation, sialorrhea, and bronchial secretions drive substantial morbidity and often explain why seemingly stable patients are struggling at home. Ventilator strategy in distress: If a ventilated ALS patient develops distress from a pulmonary process like pneumonia, manage the lung problem with standard lung-protective ventilation, including 6 mL/kg ideal body weight tidal volume.

Lit Matters 2: ER vs OR: Which is the better location for intubating?

In exsanguinating trauma, airway control can worsen shock if it delays hemorrhage control or follows inadequate resuscitation. For hypotensive injured patients headed rapidly to the OR, this paper argues for C-A-B thinking first while questioning whether ED versus OR intubation is really the causal driver of outcomes. Trauma Intubation in Active Hemorrhage Circulation before airway framing: Hemorrhagic trauma is a C-A-B problem, not a reflex A-B-C problem; positive-pressure intubation can abruptly drop preload and tip an already shocked patient into peri-intubation arrest. Study population signal: The cohort captured adults taken for hemorrhage-control surgery within 90 minutes, excluding obvious immediate-airway cases like GCS below 9 or major thoracic and face injury. Observed mortality association: Among severely injured patients, ED intubation tracked with roughly fivefold higher adjusted odds of death, but the bedside question is how much of that is procedure timing versus underlying shock. We get into that causality problem in the episode. Sicker patients in the ED group: Patients intubated in the ED arrived with more hypotension, higher shock index, more critical injury, and more transfusions, making confounding by indication the central limitation. What the paper supports: The practical takeaway is to prioritize hemorrhage control and meaningful volume resuscitation before induction unless there is a clear airway indication, while recognizing important exceptions exist. ER versus OR debate: The authors favor delaying intubation to the OR, but the sharper lesson is not location alone; it is choosing the least destabilizing sequence for a bleeding trauma patient. That distinction is worth hearing in the chapter.

Limb Ischemia

Acute limb ischemia is a limb- and life-threatening arterial occlusion in which bedside vascular exam matters more than waiting on labs. Absent Doppler flow, evolving sensory or motor deficits, and fixed mottling signal a threatened extremity that may need immediate revascularization without imaging delay. Acute Limb Ischemia Recognition Arterial flow cessation: Acute limb ischemia is sudden loss of perfusion distal to an occlusion, most often arterial thrombosis in patients with known peripheral arterial disease. High-stakes outcomes: This is uncommon at roughly 14 to 26 cases per 100,000 yearly, but mortality reaches 9% to 25% and 30-day amputation rates run 10% to 30%. Six Ps progression: Pain is the earliest and most common symptom, while pulselessness and paralysis are later findings that push concern toward irreversible ischemia. Mottling prognosis clue: Early pallor can progress to mottling, and fixed mottling is a red flag for irreversible ischemia with poor limb salvage potential. Chronic PAD pattern: Patients with baseline claudication may still have acute occlusion, but the pain is typically more sudden, more severe, and no longer resolves like prior episodes. We get into the bedside distinctions in the episode. Bedside Evaluation And Initial Management Doppler over palpation: Palpation alone is inadequate; distal pulses should be checked with Doppler, and an absent arterial signal means the limb is immediately at risk. Rutherford severity staging: The Rutherford system uses sensation, motor function, and Doppler findings to separate viable, threatened, and unsalvageable limbs and guide urgency. ABI severity marker: If Doppler flow is present, the ankle-brachial index helps grade ischemia, and an ABI below 0.40 indicates severe occlusion. CTA first-line imaging: CT angiography is the preferred imaging test, with over 99% sensitivity and 97% specificity, but severe presentations should not wait for scanning. Immediate antithrombotic therapy: With reasonable suspicion for acute occlusion, start unfractionated heparin at 80 U/kg bolus then 18 U/kg/hr infusion, plus aspirin and analgesia. Revascularization urgency: Category IIB ischemia means the limb is salvageable only with immediate revascularization, while category III with paralysis and profound sensory loss is often unsalvageable. We walk through the no-delay cases in the chapter. Etiologies And Upper Extremity Cases Thrombosis dominant cause: Arterial thrombosis causes about 80% of acute limb ischemia in patients with peripheral arterial disease, making atherosclerotic disease the usual substrate. Important alternative causes: Embolism, dissection, trauma, thrombosed popliteal aneurysm, and occluded bypass grafts can all present with the same ischemic syndrome. Embolic CTA pattern: A relatively clean vessel with abrupt occlusion and no distal flow suggests embolism, whereas a tapered cutoff with diffuse atherosclerosis favors thrombosis. Upper limb ischemia: Upper extremity cases account for about 17% of presentations and are more often cardioembolic, usually involving the axillary or brachial arteries.

Lit Matters 3: Does order of antibiotics matter?

In suspected sepsis, the first antibiotic may matter as much as the clock. When empiric therapy includes both vancomycin and a broad-spectrum beta-lactam, giving the beta-lactam first was associated with lower in-hospital mortality and avoided a meaningful delay in definitive gram-negative coverage. Antibiotic Sequence in Suspected Sepsis Beta-lactam first principle: Broad-spectrum beta-lactams should start before vancomycin in suspected sepsis, because the sequence was associated with lower in-hospital mortality in a 25,000-patient multicenter cohort. Infusion-time penalty: Vancomycin-first created a real timing cost: beta-lactam administration landed about 3 hours later, reinforcing that a long infusion can quietly delay the drug doing the early sepsis work. Mortality signal size: The adjusted mortality advantage favored beta-lactam first with an 11% lower odds of death, a clinically credible effect even after accounting for illness severity and site differences. Shock versus no-shock pattern: The association was strongest in sepsis without shock, while the septic shock subgroup did not show a clear mortality separation. We get into why that signal may differ in the episode. MRSA coverage nuance: Giving vancomycin first did not show a survival advantage even in patients with MRSA clinical cultures, underscoring that immediate MRSA coverage is not the same as vancomycin needing to hang first. Protocol-level implication: This is a systems issue more than a bedside pearl: order sets, nurse workflow, and pharmacy timing should make beta-lactam-first the default when both agents are planned. We walk through the operational implications in the chapter.